Germline pathogenic variants in the PTEN gene lead to a range of clinical outcomes including cancer syndrome phenotypes collectively known as PTEN hamartoma tumor syndrome (PHTS), and autism spectrum disorder (ASD) with macrocephaly (MIM 605309) (Lv et al., 2013). This evidence concerns the gene PTEN and PTEN hamartoma tumor syndrome.